IBDEI035 ; ; 20-FEB-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 20, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3733,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3733,1,4,0)
 ;;=4^201.90
 ;;^UTILITY(U,$J,358.3,3733,1,5,0)
 ;;=5^Hodgkin'S Lymphoma, Unpsec Type & Site
 ;;^UTILITY(U,$J,358.3,3733,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,3734,0)
 ;;=785.6^^40^258^79
 ;;^UTILITY(U,$J,358.3,3734,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3734,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,3734,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,3734,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,3735,0)
 ;;=200.20^^40^258^80
 ;;^UTILITY(U,$J,358.3,3735,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3735,1,4,0)
 ;;=4^200.20
 ;;^UTILITY(U,$J,358.3,3735,1,5,0)
 ;;=5^Lymphoma, Burkitt'S, Unspecified Sites
 ;;^UTILITY(U,$J,358.3,3735,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,3736,0)
 ;;=202.00^^40^258^82
 ;;^UTILITY(U,$J,358.3,3736,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3736,1,4,0)
 ;;=4^202.00
 ;;^UTILITY(U,$J,358.3,3736,1,5,0)
 ;;=5^Lymphoma, Low-Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,3736,2)
 ;;=^72606
 ;;^UTILITY(U,$J,358.3,3737,0)
 ;;=200.10^^40^258^81
 ;;^UTILITY(U,$J,358.3,3737,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3737,1,4,0)
 ;;=4^200.10
 ;;^UTILITY(U,$J,358.3,3737,1,5,0)
 ;;=5^Lymphoma, Int Or High Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,3737,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,3738,0)
 ;;=273.3^^40^258^83
 ;;^UTILITY(U,$J,358.3,3738,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3738,1,4,0)
 ;;=4^273.3
 ;;^UTILITY(U,$J,358.3,3738,1,5,0)
 ;;=5^Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,3738,2)
 ;;=^73013
 ;;^UTILITY(U,$J,358.3,3739,0)
 ;;=203.00^^40^258^92
 ;;^UTILITY(U,$J,358.3,3739,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3739,1,4,0)
 ;;=4^203.00
 ;;^UTILITY(U,$J,358.3,3739,1,5,0)
 ;;=5^Multiple Myeloma W/O Rem
 ;;^UTILITY(U,$J,358.3,3739,2)
 ;;=^267514
 ;;^UTILITY(U,$J,358.3,3740,0)
 ;;=203.01^^40^258^91
 ;;^UTILITY(U,$J,358.3,3740,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3740,1,4,0)
 ;;=4^203.01
 ;;^UTILITY(U,$J,358.3,3740,1,5,0)
 ;;=5^Multiple Myeloma In Remission
 ;;^UTILITY(U,$J,358.3,3740,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,3741,0)
 ;;=238.6^^40^258^95
 ;;^UTILITY(U,$J,358.3,3741,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3741,1,4,0)
 ;;=4^238.6
 ;;^UTILITY(U,$J,358.3,3741,1,5,0)
 ;;=5^Plasmacytoma Nos
 ;;^UTILITY(U,$J,358.3,3741,2)
 ;;=^81973
 ;;^UTILITY(U,$J,358.3,3742,0)
 ;;=205.00^^40^258^7
 ;;^UTILITY(U,$J,358.3,3742,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3742,1,4,0)
 ;;=4^205.00
 ;;^UTILITY(U,$J,358.3,3742,1,5,0)
 ;;=5^Aml, W/O Remission
 ;;^UTILITY(U,$J,358.3,3742,2)
 ;;=^267531
 ;;^UTILITY(U,$J,358.3,3743,0)
 ;;=205.01^^40^258^6
 ;;^UTILITY(U,$J,358.3,3743,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3743,1,4,0)
 ;;=4^205.01
 ;;^UTILITY(U,$J,358.3,3743,1,5,0)
 ;;=5^Aml, In Remission
 ;;^UTILITY(U,$J,358.3,3743,2)
 ;;=^267532
 ;;^UTILITY(U,$J,358.3,3744,0)
 ;;=205.10^^40^258^44
 ;;^UTILITY(U,$J,358.3,3744,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3744,1,4,0)
 ;;=4^205.10
 ;;^UTILITY(U,$J,358.3,3744,1,5,0)
 ;;=5^Cml, W/O Remission
 ;;^UTILITY(U,$J,358.3,3744,2)
 ;;=^267533
 ;;^UTILITY(U,$J,358.3,3745,0)
 ;;=205.11^^40^258^43
 ;;^UTILITY(U,$J,358.3,3745,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3745,1,4,0)
 ;;=4^205.11
 ;;^UTILITY(U,$J,358.3,3745,1,5,0)
 ;;=5^Cml, In Remission
 ;;^UTILITY(U,$J,358.3,3745,2)
 ;;=^267534
 ;;^UTILITY(U,$J,358.3,3746,0)
 ;;=289.0^^40^258^46
 ;;^UTILITY(U,$J,358.3,3746,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3746,1,4,0)
 ;;=4^289.0
 ;;^UTILITY(U,$J,358.3,3746,1,5,0)
 ;;=5^Erthryocytosis, Secondary
 ;;^UTILITY(U,$J,358.3,3746,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,3747,0)
 ;;=238.4^^40^258^96
 ;;^UTILITY(U,$J,358.3,3747,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3747,1,4,0)
 ;;=4^238.4
 ;;^UTILITY(U,$J,358.3,3747,1,5,0)
 ;;=5^Polycytheria Rubra Vera
 ;;^UTILITY(U,$J,358.3,3747,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,3748,0)
 ;;=V58.61^^40^258^114
 ;;^UTILITY(U,$J,358.3,3748,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3748,1,4,0)
 ;;=4^V58.61
 ;;^UTILITY(U,$J,358.3,3748,1,5,0)
 ;;=5^Warfarin/Coumadin Use
 ;;^UTILITY(U,$J,358.3,3748,2)
 ;;=Warfarin/Coumadin Use^303459
 ;;^UTILITY(U,$J,358.3,3749,0)
 ;;=282.49^^40^258^106
 ;;^UTILITY(U,$J,358.3,3749,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3749,1,4,0)
 ;;=4^282.49
 ;;^UTILITY(U,$J,358.3,3749,1,5,0)
 ;;=5^Thalassemia Nec
 ;;^UTILITY(U,$J,358.3,3749,2)
 ;;=^329910
 ;;^UTILITY(U,$J,358.3,3750,0)
 ;;=289.89^^40^258^14
 ;;^UTILITY(U,$J,358.3,3750,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3750,1,4,0)
 ;;=4^289.89
 ;;^UTILITY(U,$J,358.3,3750,1,5,0)
 ;;=5^Blood Diseases Nec
 ;;^UTILITY(U,$J,358.3,3750,2)
 ;;=^329887
 ;;^UTILITY(U,$J,358.3,3751,0)
 ;;=238.79^^40^258^77
 ;;^UTILITY(U,$J,358.3,3751,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3751,1,4,0)
 ;;=4^238.79
 ;;^UTILITY(U,$J,358.3,3751,1,5,0)
 ;;=5^LYMPH/HEMATPOITC TIS NEC
 ;;^UTILITY(U,$J,358.3,3751,2)
 ;;=^334033
 ;;^UTILITY(U,$J,358.3,3752,0)
 ;;=287.30^^40^258^97
 ;;^UTILITY(U,$J,358.3,3752,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3752,1,4,0)
 ;;=4^287.30
 ;;^UTILITY(U,$J,358.3,3752,1,5,0)
 ;;=5^Primary Thrombocytopenia
 ;;^UTILITY(U,$J,358.3,3752,2)
 ;;=^332841
 ;;^UTILITY(U,$J,358.3,3753,0)
 ;;=288.09^^40^258^3
 ;;^UTILITY(U,$J,358.3,3753,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3753,1,4,0)
 ;;=4^288.09
 ;;^UTILITY(U,$J,358.3,3753,1,5,0)
 ;;=5^Agranulocytosis
 ;;^UTILITY(U,$J,358.3,3753,2)
 ;;=^334042
 ;;^UTILITY(U,$J,358.3,3754,0)
 ;;=V10.21^^40^258^52
 ;;^UTILITY(U,$J,358.3,3754,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3754,1,4,0)
 ;;=4^V10.21
 ;;^UTILITY(U,$J,358.3,3754,1,5,0)
 ;;=5^H/O Laryngeal Cancer
 ;;^UTILITY(U,$J,358.3,3754,2)
 ;;=^295214
 ;;^UTILITY(U,$J,358.3,3755,0)
 ;;=284.2^^40^258^93
 ;;^UTILITY(U,$J,358.3,3755,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3755,1,4,0)
 ;;=4^284.2
 ;;^UTILITY(U,$J,358.3,3755,1,5,0)
 ;;=5^Myelophthisic Anemia
 ;;^UTILITY(U,$J,358.3,3755,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,3756,0)
 ;;=202.40^^40^258^65
 ;;^UTILITY(U,$J,358.3,3756,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3756,1,4,0)
 ;;=4^202.40
 ;;^UTILITY(U,$J,358.3,3756,1,5,0)
 ;;=5^Hairy Cell Leukemia,Unspecified site
 ;;^UTILITY(U,$J,358.3,3756,2)
 ;;=^69587
 ;;^UTILITY(U,$J,358.3,3757,0)
 ;;=287.49^^40^258^107
 ;;^UTILITY(U,$J,358.3,3757,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3757,1,4,0)
 ;;=4^287.49
 ;;^UTILITY(U,$J,358.3,3757,1,5,0)
 ;;=5^Thrombocytopenia,Drug Induced
 ;;^UTILITY(U,$J,358.3,3757,2)
 ;;=^339610
 ;;^UTILITY(U,$J,358.3,3758,0)
 ;;=285.9^^40^258^1
 ;;^UTILITY(U,$J,358.3,3758,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3758,1,4,0)
 ;;=4^285.9
 ;;^UTILITY(U,$J,358.3,3758,1,5,0)
 ;;=5^ANEMIA NOS
 ;;^UTILITY(U,$J,358.3,3758,2)
 ;;=^7007
 ;;^UTILITY(U,$J,358.3,3759,0)
 ;;=785.6^^40^258^78
 ;;^UTILITY(U,$J,358.3,3759,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3759,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,3759,1,5,0)
 ;;=5^LYMPHADENOPATHY
 ;;^UTILITY(U,$J,358.3,3759,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,3760,0)
 ;;=465.9^^40^259^64
 ;;^UTILITY(U,$J,358.3,3760,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3760,1,4,0)
 ;;=4^465.9
 ;;^UTILITY(U,$J,358.3,3760,1,5,0)
 ;;=5^URI
 ;;^UTILITY(U,$J,358.3,3760,2)
 ;;=URI^269878
 ;;^UTILITY(U,$J,358.3,3761,0)
 ;;=599.0^^40^259^65
 ;;^UTILITY(U,$J,358.3,3761,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3761,1,4,0)
 ;;=4^599.0
 ;;^UTILITY(U,$J,358.3,3761,1,5,0)
 ;;=5^UTI
 ;;^UTILITY(U,$J,358.3,3761,2)
 ;;=UTI^124436
 ;;^UTILITY(U,$J,358.3,3762,0)
 ;;=460.^^40^259^42
 ;;^UTILITY(U,$J,358.3,3762,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3762,1,4,0)
 ;;=4^460.
 ;;^UTILITY(U,$J,358.3,3762,1,5,0)
 ;;=5^Nasopharyngitis, Acute
 ;;^UTILITY(U,$J,358.3,3762,2)
 ;;=^26543
 ;;^UTILITY(U,$J,358.3,3763,0)
 ;;=562.11^^40^259^9
 ;;^UTILITY(U,$J,358.3,3763,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3763,1,4,0)
 ;;=4^562.11
 ;;^UTILITY(U,$J,358.3,3763,1,5,0)
 ;;=5^Diverticulitis
 ;;^UTILITY(U,$J,358.3,3763,2)
 ;;=^270274
 ;;^UTILITY(U,$J,358.3,3764,0)
 ;;=424.90^^40^259^10
 ;;^UTILITY(U,$J,358.3,3764,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3764,1,4,0)
 ;;=4^424.90
 ;;^UTILITY(U,$J,358.3,3764,1,5,0)
 ;;=5^Endocarditis
 ;;^UTILITY(U,$J,358.3,3764,2)
 ;;=^40327
 ;;^UTILITY(U,$J,358.3,3765,0)
 ;;=558.9^^40^259^17
 ;;^UTILITY(U,$J,358.3,3765,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3765,1,4,0)
 ;;=4^558.9
 ;;^UTILITY(U,$J,358.3,3765,1,5,0)
 ;;=5^Gastroenteritis
 ;;^UTILITY(U,$J,358.3,3765,2)
 ;;=^87311
 ;;^UTILITY(U,$J,358.3,3766,0)
 ;;=054.71^^40^259^30
 ;;^UTILITY(U,$J,358.3,3766,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3766,1,4,0)
 ;;=4^054.71
 ;;^UTILITY(U,$J,358.3,3766,1,5,0)
 ;;=5^Herpes Simplex,Visceral
 ;;^UTILITY(U,$J,358.3,3766,2)
 ;;=^266574
 ;;^UTILITY(U,$J,358.3,3767,0)
 ;;=054.10^^40^259^18
 ;;^UTILITY(U,$J,358.3,3767,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3767,1,4,0)
 ;;=4^054.10
 ;;^UTILITY(U,$J,358.3,3767,1,5,0)
 ;;=5^Genital Herpes, Unsp
 ;;^UTILITY(U,$J,358.3,3767,2)
 ;;=^56853
 ;;^UTILITY(U,$J,358.3,3768,0)
 ;;=054.13^^40^259^32
 ;;^UTILITY(U,$J,358.3,3768,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3768,1,4,0)
 ;;=4^054.13
 ;;^UTILITY(U,$J,358.3,3768,1,5,0)
 ;;=5^Herpetic Infect Of Penis
 ;;^UTILITY(U,$J,358.3,3768,2)
 ;;=^266560
 ;;^UTILITY(U,$J,358.3,3769,0)
 ;;=054.11^^40^259^33
 ;;^UTILITY(U,$J,358.3,3769,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3769,1,4,0)
 ;;=4^054.11
 ;;^UTILITY(U,$J,358.3,3769,1,5,0)
 ;;=5^Herpetic Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,3769,2)
 ;;=^57012
 ;;^UTILITY(U,$J,358.3,3770,0)
 ;;=053.9^^40^259^31
 ;;^UTILITY(U,$J,358.3,3770,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3770,1,4,0)
 ;;=4^053.9
 ;;^UTILITY(U,$J,358.3,3770,1,5,0)
 ;;=5^Herpes Zoster Nos
 ;;^UTILITY(U,$J,358.3,3770,2)
 ;;=^56946
 ;;^UTILITY(U,$J,358.3,3771,0)
 ;;=487.1^^40^259^34
 ;;^UTILITY(U,$J,358.3,3771,1,0)
 ;;=^358.31IA^5^2
